Table 3.

Duration of rivaroxaban treatment for labelled indications

Duration of treatment episode	No. of episodes
Elective KR, revision of KR	N = 157
<11 days	3 (1.9 %)
11–<14 days	2 (1.3 %)
14 days	2 (1.3 %)
>14–21 days	35 (22.3 %)
>21–35 days	32 (20.4 %)
>35 days	83 (52.9 %)
Elective HR, revision of HR	N = 206
<4 weeks	73 (35.4 %)
4–<5 weeks	15 (7.3 %)
5 weeks	2 (1.0 %)
>5–6 weeks	58 (28.2 %)
>6 weeks	58 (28.2 %)

Recommended treatment durations for rivaroxaban according to the SPC are 14 days in patients undergoing KR and 5 weeks in those undergoing HR. The German S3-Guideline generally recommends thromboprophylaxis for 11–14 days after KR and for 4–5 weeks after HR, respectively